Pulse Provides 1st Quarter Results and Corporate Update

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pulse Provides 1st Quarter Results and Corporate Update

DENVER, CO--(Marketwired - May 16, 2013) -  The Pulse Beverage Corporation ( OTCQB : PLSB ) ("Pulse") , makers of PULSE® brand of functional beverages and Cabana™ 100% Natural Lemonade, today announced its 1 st Quarter results for 2013 and issued a corporate update.

Q1-2013 Highlights:

Case sales during Q1-2013 for Cabana™ increased 169% quarter over quarter and 133% as compared to Q1-2012. Revenue during Q1-2013 for Cabana™ increased by 232% quarter over quarter and 115% as compared to Q1-2012.

Pulse's Q1-2013 net loss from operations was expected and was a result of costs associated with improvements made to its flagship product PULSE®, expanding its distribution system, costs associated with securing chain store listings, cost and shipping of samples of both products to distributors and chain store buyers. Pulse expects to be operationally cash flow positive by the end of Q2-2013. We expect Cabana™ to reach the annualized one million case threshold by the end of Q2-2013. This is a very meaningful accomplishment for Pulse as well-respected beverage publications generally report that it normally takes four to six years to reach corporate profitability and annualized one million case threshold for new beverage brands.

During Q1-2013 grocery and convenience store chain store listings for Cabana™ increased by 4,000 listings to more than 11,000. An additional 2,000 chain store listings have been secured for Cabana™ since March 31, 2013 to a total of 13,000. It generally takes four to five months between securing a listing and having product on the shelf for sale to consumers. Some of the more notable chains carrying, or committed to carrying, Cabana™ are: Safeway Inc. including Vons and all banners, Sobeys (Canada), Albertsons, Walgreens, Whole Foods (selected divisions), Kroger (selected divisions), Hy-Vee, Roundy's Supermarkets, Hannaford and Sprouts. Pulse is in the process of securing many more chain store listings for both PULSE® and Cabana™. Some of these will soon be carrying PULSE® as well.

Pulse has in excess of $4.5 million in working capital as at March 31, 2013 including cash of $3.8 million, as such, Pulse will likely not need additional capital to finance the growth of its operations for its PULSE® and Cabana™ products. Pulse has received several offers for additional financing but has turned the offers down as it doesn't require additional financing for the foreseeable future.

Introduction of PULSE®

Pulse has recently completed its first commercial production run of PULSE® with improved packaging and flavor profiles from its initial pre-commercial production run completed in February 2013. Pulse has secured a large new distributor for Ohio/Kentucky and its largest Southern California distributor has also agreed to distribute PULSE®. Two-thirds of the run has been shipped to these two distributors.

Future Growth and Expansion Plans

Pulse's growth and expansion plans include:

  • securing additional distributors, chain store, convenience store and key account listings for its products across United States and internationally;
  • providing online shopping through a new and improved website by the end of Q2-2013;
  • furthering discussions with distribution partners in Asia, in particular, China, for distribution of both PULSE® and Cabana™ products;
  • increasing brand awareness of PULSE®;
  • acquiring additional brands that complement its product mix;
  • expanding its PULSE® brand by developing new proprietary formulations; and
  • introducing a third branded product closely associated with the PULSE® health platforms.

About The Pulse Beverage Corporation 

The Pulse Beverage Corporation is an emerging growth beverage company that manufactures and distributes Cabana™ 100% Natural Lemonade and PULSE® brand of functional beverages -- originally developed by a major healthcare company, in three health platforms: PULSE® Heart Health Formula™, PULSE® Women's Health Formula™ and PULSE® Men's Health Formula™.

For more information visit: www.pulsebeverage.com or email info@pulsebeverage.com .

Forward-Looking Statements This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, regulatory incentives, the development of new business opportunities, and projected costs, revenue, profits and results operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

 

Shareholder Relations: Martin E. Janis & Company, Inc. 877-302-6404 investors@pulsebeverage.com www.pulsebeverage.com Investor and Broker Relations: Acorn Management Partners LLC Lance A. Beckham 678-368-4012 lbeckham@acornmanagementpartners.com Media and Research Analysts: Bev Jedynak 312-943-1123 bjedynak@janispr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Kohl's Stock Plummets Amid Retail Challenges and Restructuring

Updated Category News Views 589

Kohl's Corporation Faces Significant Challenges Kohl's Corporation (NYSE: KSS) has recently seen its stock plummet to a concerning 52-week low of $13.61. This decline paints a grim picture of the current retail environment, where shifting consumer habits and fierce competition play a pivotal role. Priced at just 0.4 times book value and boasting a generous 14.5% dividend...

Continue Reading
Rapid Micro Biosystems Achieves Record Growth and Future Outlook

Updated Category News Views 136

Financial Performance Highlights for Rapid Micro Biosystems Rapid Micro Biosystems, Inc. (NASDAQ: RPID) has announced impressive results for the fourth quarter and the entire fiscal year of 2024. The company recorded a total revenue of $8.2 million in the fourth quarter, marking a 30% increase compared to the same period in 2023. Likewise, the full year revenue reached...

Continue Reading
ALZpath and Siemens Team Up for Advanced Alzheimer's Testing

Updated Category News Views 265

ALZpath and Siemens Healthineers Form Strategic Partnership ALZpath is thrilled to announce a significant licensing agreement with Siemens Healthineers. This collaboration marks a pivotal enhancement in the accessibility of diagnostic testing for Alzheimer's disease. The agreement involves the use of ALZpath's proprietary pTau217 antibody, a remarkable tool for...

Continue Reading
Generate:Biomedicines Showcases Promising Results for GB-0895

Updated Category News Views 495

Results from Phase 1 Trials of GB-0895 Unveiled Generate:Biomedicines is making notable headlines with its innovative drug GB-0895. This cutting-edge treatment is an ultra-high affinity anti-TSLP monoclonal antibody, specifically designed for individuals grappling with asthma. With a unique formulation, GB-0895 offers a prolonged half-life and sustained pharmacological...

Continue Reading
Driving Growth in Natural Stone Market and Its Future

Updated Category News Views 226

Steady Growth in the Natural Stone Market The natural stone market is on a promising upward trajectory, predicted to rise from USD 37.89 billion to USD 47.63 billion by a future date, indicating a compound annual growth rate (CAGR) of 4.68%. Various factors are driving this growth, most notably the intense infrastructure investment blooming worldwide. The construction...

Continue Reading